We are live on ! Find out more
EDSA icon

Edesa Biotech
EDSA

10 hedge funds and large institutions have $58K invested in Edesa Biotech in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.05% less ownership

Funds ownership: 0.08% → 0.03% (-0.05%)

41% less funds holding

Funds holding: 17 → 10 (-7)

76% less capital invested

Capital invested by funds: $241K → $58K (-$183K)

88% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 8

Holders
10
Holders Change
-7
Holders Change %
-41.18%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$33.1K
2
UBS Group
UBS Group
Switzerland
+$11.1K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$65K
2
Jane Street
Jane Street
New York
-$28K
3
TSS
Two Sigma Securities
New York
-$28K
4
Millennium Management
Millennium Management
New York
-$24K
5
VF
Virtu Financial
New York
-$23K

EDSA Hedge Fund Activity: Q4 2018 in Review

10 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q4 2018, worth a combined $58K — down 76% from $241K a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of EDSA and 1 opened new positions — a net loss of 7 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was Renaissance Technologies, adding an estimated $33.1K. The largest seller was Sabby Management, exiting entirely with an estimated $65K sold.

  • 10 institutional investors held Edesa Biotech (EDSA) as of Q4 2018, down from 17 in Q3 2018.
  • Funds reported $58K of Edesa Biotech stock for Q4 2018, down 76% quarter-over-quarter.
  • 1 fund opened new Edesa Biotech positions in Q4 2018 and 8 closed out, a net change of -7 holders.
  • The largest Edesa Biotech buyer in Q4 2018 was Renaissance Technologies, an estimated $33.1K added.
  • The largest Edesa Biotech seller in Q4 2018 was Sabby Management, an estimated $65K sold.

Based on aggregated 13F filings for Q4 2018.